臨床試験アウトソーシング市場は、臨床研究の複雑さとコストの増加により、予測期間中に943億ドルに達すると予想されます。この成長の主な要因には、研究開発費の増加、医薬品開発パイプラインの拡大、臨床試験のグローバル化などがあります。CROへのアウトソーシングは、企業がこれらの複雑さを効率的に管理するのに役立ちます。しかし、市場は、さまざまな国の規制遵守、データセキュリティと患者の機密性、高品質基準の維持、複数のステークホルダー間のコミュニケーションの管理、競争環境のナビゲートなど、いくつかの課題に直面しています。これらのハードルにもかかわらず、企業が新しい治療法を市場に投入するための費用対効果が高く効率的な方法を求めるにつれて、アウトソーシングの需要は高まると予想されます。
目次
Table of Content
Table of Content
1. Executive Summary
1.1. Regional Market Share
1.2. Business Trends
1.3. Clinical Trials Outsourcing Market: COVID-19 Outbreak
1.4. Regional Trends
1.5. Segmentation Snapshot
2. Research Methodology
2.1. Research Objective
2.2. Research Approach
2.3. Data Sourcing and Methodology
2.4. Primary Research
2.5. Secondary Research
2.5.1. Paid Sources
2.5.2. Public Sources
2.6. Market Size Estimation and Data Triangulation
3. Market Characteristics
3.1. Market Definition
3.2. Clinical Trials Outsourcing Market: COVID-19 Impact
3.3. Key Segmentations
3.4. Key Developments
3.5. Allied Industry Data
4. Clinical Trials Outsourcing Market - Industry Insights
4.1. Industry Segmentation
4.2. COVID-19 overview of world economy
4.3. Industry Ecosystem Channel Analysis
4.4. Innovation & Sustainability
5. Macroeconomic Indicators
6. Recent Developments
7. Market Dynamics
7.1. Introduction
7.2. Growth Drivers
7.3. Market Opportunities
7.4. Market Restraints
7.5. Market Trends
8. Risk Analysis
9. Market Analysis
9.1. Porter's Five Forces
9.2. PEST Analysis
9.2.1. Political
9.2.2. Economic
9.2.3. Social
9.2.4. Technological
10. Clinical Trials Outsourcing Market
10.1. Overview
10.2. Historical Analysis (2019-2022)
10.2.1. Market Size, Y-o-Y Growth (%) and Market Forecast
11. Clinical Trials Outsourcing Market Size & Forecast 2024A-2034F
11.1. Overview
11.2. Key Findings
11.3. Market Segmentation
11.3.1. By Phase
11.3.1.1. Phase I
11.3.1.1.1. By Value (USD Million) 2024-2034F
11.3.1.1.2. Market Share (%) 2024-2034F
11.3.1.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.1.2. Phase II
11.3.1.2.1. By Value (USD Million) 2024-2034F
11.3.1.2.2. Market Share (%) 2024-2034F
11.3.1.2.3. Y-o-Y Growth (%) 2024-2034F
11.3.1.3. Phase III
11.3.1.3.1. By Value (USD Million) 2024-2034F
11.3.1.3.2. Market Share (%) 2024-2034F
11.3.1.3.3. Y-o-Y Growth (%) 2024-2034F
11.3.1.4. Phase IV
11.3.1.4.1. By Value (USD Million) 2024-2034F
11.3.1.4.2. Market Share (%) 2024-2034F
11.3.1.4.3. Y-o-Y Growth (%) 2024-2034F
11.3.2. By Application
11.3.2.1. Cancer
11.3.2.1.1. By Value (USD Million) 2024-2034F
11.3.2.1.2. Market Share (%) 2024-2034F
11.3.2.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.2.2. Cardiovascular Diseases
11.3.2.2.1. By Value (USD Million) 2024-2034F
11.3.2.2.2. Market Share (%) 2024-2034F
11.3.2.2.3. Y-o-Y Growth (%) 2024-2034F
11.3.2.3. Nervous System Diseases
11.3.2.3.1. By Value (USD Million) 2024-2034F
11.3.2.3.2. Market Share (%) 2024-2034F
11.3.2.3.3. Y-o-Y Growth (%) 2024-2034F
11.3.2.4. Infectious Diseases
11.3.2.4.1. By Value (USD Million) 2024-2034F
11.3.2.4.2. Market Share (%) 2024-2034F
11.3.2.4.3. Y-o-Y Growth (%) 2024-2034F
11.3.2.5. Musculoskeletal Disease
11.3.2.5.1. By Value (USD Million) 2024-2034F
11.3.2.5.2. Market Share (%) 2024-2034F
11.3.2.5.3. Y-o-Y Growth (%) 2024-2034F
11.3.2.6. Gastroenterology Diseases
11.3.2.6.1. By Value (USD Million) 2024-2034F
11.3.2.6.2. Market Share (%) 2024-2034F
11.3.2.6.3. Y-o-Y Growth (%) 2024-2034F
11.3.2.7. Others
11.3.2.7.1. By Value (USD Million) 2024-2034F
11.3.2.7.2. Market Share (%) 2024-2034F
11.3.2.7.3. Y-o-Y Growth (%) 2024-2034F
11.3.3. By Services Type
11.3.3.1. Protocol Designing
11.3.3.1.1. By Value (USD Million) 2024-2034F
11.3.3.1.2. Market Share (%) 2024-2034F
11.3.3.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.2. Site Identification
11.3.3.2.1. By Value (USD Million) 2024-2034F
11.3.3.2.2. Market Share (%) 2024-2034F
11.3.3.2.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.3. Patient Recruitment
11.3.3.3.1. By Value (USD Million) 2024-2034F
11.3.3.3.2. Market Share (%) 2024-2034F
11.3.3.3.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.4. Laboratory Services
11.3.3.4.1. By Value (USD Million) 2024-2034F
11.3.3.4.2. Market Share (%) 2024-2034F
11.3.3.4.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.5. Bioanalytical Testing Services
11.3.3.5.1. By Value (USD Million) 2024-2034F
11.3.3.5.2. Market Share (%) 2024-2034F
11.3.3.5.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.6. Clinical Trial Data Management Services
11.3.3.6.1. By Value (USD Million) 2024-2034F
11.3.3.6.2. Market Share (%) 2024-2034F
11.3.3.6.3. Y-o-Y Growth (%) 2024-2034F
11.3.3.7. Others
11.3.3.7.1. By Value (USD Million) 2024-2034F
11.3.3.7.2. Market Share (%) 2024-2034F
11.3.3.7.3. Y-o-Y Growth (%) 2024-2034F
11.3.4. By End-User
11.3.4.1. Pharmaceutical & Biopharmaceutical Companies
11.3.4.1.1. By Value (USD Million) 2024-2034F
11.3.4.1.2. Market Share (%) 2024-2034F
11.3.4.1.3. Y-o-Y Growth (%) 2024-2034F
11.3.4.2. Medical Device Companies
11.3.4.2.1. By Value (USD Million) 2024-2034F
11.3.4.2.2. Market Share (%) 2024-2034F
11.3.4.2.3. Y-o-Y Growth (%) 2024-2034F
11.3.4.3. Others
11.3.4.3.1. By Value (USD Million) 2024-2034F
11.3.4.3.2. Market Share (%) 2024-2034F
11.3.4.3.3. Y-o-Y Growth (%) 2024-2034F
12. North America Clinical Trials Outsourcing Market Size & Forecast 2024A-2034F
12.1. Overview
12.2. Key Findings
12.3. Market Segmentation
12.3.1. By Phase
12.3.2. By Application
12.3.3. By Services Type
12.3.4. By End-User
12.4. Country
12.4.1. United States
12.4.2. Canada
13. Europe Clinical Trials Outsourcing Market Size & Forecast 2024A-2034F
13.1. Overview
13.2. Key Findings
13.3. Market Segmentation
13.3.1. By Phase
13.3.2. By Application
13.3.3. By Services Type
13.3.4. By End-User
13.4. Country
13.4.1. Germany
13.4.2. United Kingdom
13.4.3. France
13.4.4. Italy
13.4.5. Spain
13.4.6. Russia
13.4.7. Rest of Europe (BENELUX, NORDIC, Hungary, Turkey & Poland)
14. Asia-Pacific Clinical Trials Outsourcing Market Size & Forecast 2024A-2034F
14.1. Overview
14.2. Key Findings
14.3. Market Segmentation
14.3.1. By Phase
14.3.2. By Application
14.3.3. By Services Type
14.3.4. By End-User
14.4. Country
14.4.1. India
14.4.2. China
14.4.3. South Korea
14.4.4. Japan
14.4.5. Rest of APAC
15. Middle East and Africa Clinical Trials Outsourcing Market Size & Forecast 2024A-2034F
15.1. Overview
15.2. Key Findings
15.3. Market Segmentation
15.3.1. By Phase
15.3.2. By Application
15.3.3. By Services Type
15.3.4. By End-User
15.4. Country
15.4.1. Israel
15.4.2. GCC
15.4.3. North Africa
15.4.4. South Africa
15.4.5. Rest of Middle East and Africa
16. Latin America Clinical Trials Outsourcing Market Size & Forecast 2024A-2034F
16.1. Overview
16.2. Key Findings
16.3. Market Segmentation
16.3.1. By Phase
16.3.2. By Application
16.3.3. By Services Type
16.3.4. By End-User
16.4. Country
16.4.1. Mexico
16.4.2. Brazil
16.4.3. Rest of Latin America
17. Competitive Landscape
17.1. Company market share, 2023
17.2. Key player overview
17.3. Key stakeholders
18. Company Profiles
18.1. QuintilesIMS (IQVIA)
18.1.1. Company Overview
18.1.2. Financial Overview
18.1.3. Key Product; Analysis
18.1.4. Company Assessment
18.1.4.1. Product Portfolio
18.1.4.2. Key Clients
18.1.4.3. Market Share
18.1.4.4. Recent News & Development (Last 3 Yrs.)
18.1.4.5. Executive Team
18.2. Covance (LabCorp)
18.3. Parexel International
18.4. Charles River Laboratories
18.5. Medpace
18.6. ICON plc
18.7. PRA Health Sciences
18.8. Syneos Health
18.9. Wuxi AppTec
18.10. PPD
18.11. Eurofins Scientific
18.12. Clinipace
18.13. KCR
18.14. Worldwide Clinical Trials
18.15. Advanced Clinical
18.16. Other Prominent Players
19. Appendix
20. Consultant Recommendation
